SCHEMBL22980156

SCHEMBL22980156

CCCCOC(=O)N1CC(NC(=O)OCc2ccccc2)CC1C(=O)OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 3/20 0.47
CPB1 P15086 1/20 0.46
ALDH1A1 P00352 4/20 0.44
GAA P10253 1/20 0.44
CTSL P07711 1/20 0.44
CTSB P07858 1/20 0.44
CTSK P43235 1/20 0.44
TSHR P16473 4/20 0.43
CYP3A4 P08684 3/20 0.43
MAPK1 P28482 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HSD11B1 P28845 1/20 0.43
ANPEP P15144 1/20 0.41
TLR4 O00206 1/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
CYP1A2 P05177 1/20 0.41
POLB P06746 1/20 0.41
CYP2D6 P10635 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23532515 0.85 MMP2 (0.55) MMP2CPB1ALDH1A1GAACTSL
SCHEMBL13182492 0.85 MMP2 (0.67) MMP2ANPEP
SCHEMBL13182579 0.85 MMP2 (0.67) MMP2ANPEP
SCHEMBL29580842 0.84 MMP2 (0.49) MMP2CPB1ALDH1A1GAACTSL
SCHEMBL19942971 0.84 MMP2 (0.49) MMP2CPB1ALDH1A1GAACTSL
SCHEMBL489584 0.84 MMP2 (0.49) MMP2CPB1ALDH1A1GAACTSL
SCHEMBL25184486 0.84 MMP2 (0.49) MMP2CPB1ALDH1A1GAACTSL
SCHEMBL24538203 0.84 MMP2 (0.49) MMP2CPB1ALDH1A1GAACTSL
SCHEMBL9006101 0.84 MMP2 (0.49) MMP2CPB1ALDH1A1GAACTSL
SCHEMBL25551181 0.84 MMP2 (0.49) MMP2CPB1ALDH1A1GAACTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4010080-A1 HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER Artios Pharma Limited (GB) 2022-06-15 EP disclosed
WO-2021028643-A1 HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER ARTIOS PHARMA LIMITED (GB) 2021-02-18 WO disclosed